Type
1.
Yang J, Li X, Sun Y, Zhang L, Jin G, Li G, et al. Global epidemiology of leprosy from 2010 to 2020: A systematic review and meta-analysis of the proportion of sex, type, grade 2 deformity and age. Pathogens and global health. 2022;:1-10.
Type
1.
Shravani B, Ganguly S, Shukla AK, Chhabra N, Prabha N, Sachdev D, et al. Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India. Journal of family medicine and primary care [Internet]. 2022;11(4):1416-20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067199/pdf/JFMPC-11-1416.pdf
Type
1.
Kabo AK, Kaman K, Doungous DM, Ouedraogo L, Abakar M, Godreuil S, et al. [Epidemiology of leprosy in Chad from 2015 to 2019]. The Pan African medical journal [Internet]. 2022;41:120. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994465/pdf/PAMJ-41-120.pdf
Type
1.
Aubry A, Rosa S, Chauffour A, Fletcher L, Cambau E, Avanzi C. Drug resistance in leprosy: an update following 70 years of chemotherapy. Infectious diseases now [Internet]. 2022; Available from: https://www.sciencedirect.com/science/article/pii/S2666991922000665
Type
1.
de Oliveira ALG, Chaves AT, Cardoso MS, Pinheiro GRG, Antunes DE, Grossi MA de F, et al. Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients. Microbes and infection. 2022;:104981.
Type
1.
Pinheiro LCS, Borges JC, Campos VR, Dantas LC. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy. Mini reviews in medicinal chemistry. 2022;
Type
1.
Andrade ESN, Brandão JG, da Silva JS, Coriolano CRF, Rosa PS, Moraes MO, et al. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial agents and chemotherapy. 2022;:e0217021.
Type
1.
Jindal R, Nagrani P, Chauhan P, Bisht YS, Sethi S, Roy S. Nutritional Status of Patients With Leprosy Attending a Tertiary Care Institute in North India. Cureus [Internet]. 2022;14(3):e23217. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012245/pdf/cureus-0014-00000023217.pdf
Type
1.
Cardona-Castro N, Escobar-Builes MV, Serrano-Coll H, Adams LB, Lahiri R. Mycobacterium lepromatosis as Cause of Leprosy, Colombia. Emerging infectious diseases [Internet]. 2022;28(5):1067-8. Available from: https://wwwnc.cdc.gov/eid/article/28/5/pdfs/21-2015-combined.pdf
Type
1.
de Sousa JR, Falcão LFM, Virgolino GL, Cruz MFS, Teixeira VF, Aarão TL de S, et al. Different cell death mechanisms are involved in leprosy pathogenesis. Microbial pathogenesis. 2022;166:105511.
Pagination
- Previous page
- Page 29
- Next page